EUVIMEDEUVIMED entdecken
Crossref

Cholesterol-Lowering Treatment Suppresses Neuromuscular Transmission Via Presynaptic Mechanism at the Mouse Diaphragm Muscle

Guzel F Zakyrjanova, Andrei N Tsentsevitsky, Valeriya A Matigorova, Nikita S Fedorov, Julia G Odnoshivkina, Guzel V Sibgatullina, Eva A Kapliukhina, Arthur R Giniatullin, Arthur N Khaziev, Artem I Malomouzh, Yuri V Gogolev, Alexey M Petrov

Neurochemical Research · 2025

DOI: 10.1007/s11064-025-04550-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neurochemical Research, 2025. Verfasst von Guzel F Zakyrjanova und 11 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Biophysics of Synaptic Processes, Kazan Institute of Biochemistry and Biophysics, Federal Research Center - Kazan Scientific Center of …. Hauptthemen laut MEDLINE: Diaphragm, Synaptic Transmission, Atorvastatin, Neuromuscular Junction. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 151 Literaturangaben. Gefördert von: Russian Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Statins are widely prescribed and effective cholesterol-lowering drugs for the therapy of cerebrovascular and cardiovascular disorders. The main side effects limiting statin use are muscle-related adverse events, including weakness and myopathy. The precise mechanisms of statin-induced muscle damage remain to be elucidated. Possible alterations in neuromuscular transmission might contribute to the statin side effects. Here, we studied the action of one-month treatment with atorvastatin, the most prescribed statin, on the functioning of neuromuscular junctions and related processes in the mouse diaphragm. We found that atorvastatin treatment decreases evoked acetylcholine (ACh) release and involvement of synaptic vesicles in exocytosis during intense nerve activation, as well as recovery of ACh release after tetanic stimulation. This was accompanied by increased immunolabeling of synapsin 1, a protein retaining synaptic vesicles in a non-active pool, and decreased non-quantal ACh release under resting conditions. Additionally, atorvastatin administration decreased perimeters of postsynaptic ACh receptor clusters without signs of muscle denervation. Diaphragm contractile responses to phrenic nerve stimulation at moderate-to-high frequencies and peak inspiratory flow, an indicator of diaphragm function in vivo, were decreased in atorvastatin-treated mice, whereas diaphragm contractions elicited by direct stimulation of muscle fibers were unchanged. Thus, atorvastatin treatment caused a decline in evoked ACh release and synaptic vesicle recruitment into neurotransmission that could lead to a reduction of diaphragm contractile responses to phrenic nerve activity and peak inspiratory flow. These alterations, in combination with decreased non-quantal ACh release and neuromuscular junction size, may contribute to statin-associated muscle symptoms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DiaphragmSynaptic TransmissionAtorvastatinNeuromuscular JunctionAnticholesteremic AgentsAnimalsMaleMiceMice, Inbred C57BLAcetylcholineMuscle ContractionPhrenic NerveSynaptic Vesicles

Stichwörter der Autor:innen

AtorvastatinExocytosisMuscle contractionNeuromuscular junctionNeurotransmitter releaseStatin-associated muscle symptoms

Substanzen

AtorvastatinAnticholesteremic AgentsAcetylcholine

Autor:innen und Institutionen

  • Laboratory of Biophysics of Synaptic Processes, Kazan Institute of Biochemistry and Biophysics, Federal Research Center - Kazan Scientific Center of RAS, 2/31 Lobachevsky Street, Kazan, 420111, Russia.
  • Department of Human and Animal Physiology, Lomonosov Moscow State University, Leninskiye gory, 1, 12, Moscow, 119234, Russia.
  • Department of Normal Physiology, Institute of Neuroscience, Kazan State Medical University, 49 Butlerova Street, Kazan, 420012, Russia.
  • Kazan National Research Technical University, 10, K. Marx St., Kazan, 420111, Russia.
  • Institute of Fundamental Medicine and Biology, Kazan (Volga Region) Federal University, Kazan, 420008, Russia.
  • Laboratory of Biophysics of Synaptic Processes, Kazan Institute of Biochemistry and Biophysics, Federal Research Center - Kazan Scientific Center of RAS, 2/31 Lobachevsky Street, Kazan, 420111, Russia. alexey.petrov@kaz…

Förderung

  • Russian Science Foundation

Zitieren

APA

Zakyrjanova, G. F., Tsentsevitsky, A. N., Matigorova, V. A., Fedorov, N. S., Odnoshivkina, J. G., Sibgatullina, G. V., Kapliukhina, E. A., Giniatullin, A. R., Khaziev, A. N., Malomouzh, A. I., Gogolev, Y. V., & Petrov, A. M. (2025). Cholesterol-Lowering Treatment Suppresses Neuromuscular Transmission Via Presynaptic Mechanism at the Mouse Diaphragm Muscle. Neurochemical Research. https://doi.org/10.1007/s11064-025-04550-4

Vancouver

Zakyrjanova GF, Tsentsevitsky AN, Matigorova VA, Fedorov NS, Odnoshivkina JG, Sibgatullina GV, et al. Cholesterol-Lowering Treatment Suppresses Neuromuscular Transmission Via Presynaptic Mechanism at the Mouse Diaphragm Muscle. Neurochemical Research. 2025. doi:10.1007/s11064-025-04550-4

BibTeX
@article{Zakyrjanova2025,
  author = {Zakyrjanova, Guzel F and Tsentsevitsky, Andrei N and Matigorova, Valeriya A and Fedorov, Nikita S and Odnoshivkina, Julia G and Sibgatullina, Guzel V and Kapliukhina, Eva A and Giniatullin, Arthur R and Khaziev, Arthur N and Malomouzh, Artem I and Gogolev, Yuri V and Petrov, Alexey M},
  title = {Cholesterol-Lowering Treatment Suppresses Neuromuscular Transmission Via Presynaptic Mechanism at the Mouse Diaphragm Muscle},
  journal = {Neurochemical Research},
  year = {2025},
  doi = {10.1007/s11064-025-04550-4}
}
Kostenlos starten →